COMPARATIVE RECEPTOR AUTORADIOGRAPHY OF EX-VIVO AND IN-VITRO [H-3] DIZOCILPINE BINDING IN MOUSE-BRAIN AFTER MIDDLE CEREBRAL-ARTERY OCCLUSION

Citation
R. Carletti et al., COMPARATIVE RECEPTOR AUTORADIOGRAPHY OF EX-VIVO AND IN-VITRO [H-3] DIZOCILPINE BINDING IN MOUSE-BRAIN AFTER MIDDLE CEREBRAL-ARTERY OCCLUSION, Neuropharmacology, 33(1), 1994, pp. 43-53
Citations number
39
Categorie Soggetti
Pharmacology & Pharmacy",Neurosciences
Journal title
ISSN journal
00283908
Volume
33
Issue
1
Year of publication
1994
Pages
43 - 53
Database
ISI
SICI code
0028-3908(1994)33:1<43:CRAOEA>2.0.ZU;2-#
Abstract
In the present study the in vitro and ex vivo distributions of [H-3]di zocilpine binding sites in mouse brain after middle cerebral artery oc clusion (MCA-O) were compared using receptor autoradiography. The dist ribution patterns of [H-3]dizocilpine binding sites obtained in vitro and ex vivo in normal mouse brain were the same with the highest densi ties occurring in the hippocampus and cerebral cortex. MCA-O had littl e or no effect on the in vitro binding density for at least 24 hr post -ischaemia. However after 2-3 days binding densities in the region of infarct were significantly reduced compared to the contralateral cereb ral cortex. Further reductions occurred after 5-7 days. By contrast ex vivo [H-3]dizocilpine binding was reduced in the infarcted area by 78 .7 +/- 4% within 2 hr of the ischaemic insult and at all subsequent ti mes binding was reduced by more than 75%. Ex vivo binding after ischae mia was always less than 30% of in vitro binding and this decrease was apparent within 2 hr of the ischaemic insult whereas in vitro binding was maintained at control levels for at least 24 hr. The neuroprotect ive activity of the NMDA antagonists dizocilpine and CGP 37849 in this model at different times after MCA-O was assessed. The time scale for receptor access following MCA-O is discussed and it is suggested that although the population of NMDA receptors is maintained in the infarc t region for some days access to them in vivo may be sufficiently impa ired within 2 or 4 hr of ischaemic insult to reduce the neuroprotectiv e activity of NMDA antagonists after this time.